EPITHELIAL TISSUE REGENERATION DURING INFLAMMATION: CELLULAR MECHANISMS AND CLINICAL SIGNIFICANCE

ISSN: 2582-4686 SJIF 2021-3.261,SJIF 20222.889, 2024-6.875 ResearchBib IF: 9.948 / 2024 VOLUME-5, ISSUE-12 240 EPITHELIAL TISSUE REGENERATION DURING INFLAMMATION: CELLULAR MECHANISMS AND CLINICAL SIGNIFICANCE Amanov Kobiljon Associate Professor of the Department of Medical Biology and Histology Andijan State Medical Institute Abstract. This article explores the cellular and molecular mechanisms of epithelial tissue regeneration during inflammation and highlights its clinical significance across multiple organ systems. Epithelial repair is mediated through coordinated activation of resident stem and progenitor cells, dedifferentiation of mature epithelial cells, restitution-driven migration, extracellular matrix remodeling, and tightly regulated cytokine signaling. The interplay between epithelial and mesenchymal compartments, along with key pathways such as NF-κB, STAT3, Wnt/β-catenin, Notch, and TGF-β, determines whether regeneration proceeds toward healthy restoration or pathological remodeling. The article emphasizes how chronic inflammation disrupts regenerative balance, contributing to metaplasia, fibrosis, barrier dysfunction, and inflammation-associated carcinogenesis. Understanding these processes provides a foundation for therapeutic strategies aimed at improving mucosal healing and epithelial repair in dermatological, gastrointestinal, respiratory, and regenerative-medicine contexts. Kеywоrds: epithelial regeneration, inflammation, stem cells, restitution, cytokines, extracellular matrix, NF-κB, STAT3, tissue remodeling. INTRОDUСTIОN Epithelial tissues serve as the primary protective barrier of the human body, forming the first line of defense against mechanical injury, pathogens, toxins, and environmental stress. During inflammation, epithelial structures face significant cellular damage due to immune-cell infiltration, oxidative stress, cytokine signaling, and microbial assault. Despite these challenges, epithelial tissues demonstrate remarkable regenerative capacity, orchestrated through a tightly regulated interplay between stem cells, immune mediators, extracellular matrix remodeling, and molecular signaling pathways. Understanding these mechanisms is critical, as epithelial regeneration determines whether inflamed tissue returns to normal function or progresses toward chronic injury, fibrosis, or carcinogenesis. MАTЕRIАLS АND MЕTHОDS At the cellular level, epithelial regeneration begins with activation of resident stem and progenitor cells located within specialized niches such as intestinal crypts, basal layers of stratified squamous epithelia, and glandular structures of the respiratory and reproductive systems. Inflammation triggers the release of growth factors — including EGF, TGF-α, HGF, and Wnt ligands — which stimulate these progenitor cells to re-enter the cell cycle, proliferate, and migrate toward the site of injury [1]. Simultaneously, surviving epithelial cells undergo dedifferentiation, temporarily reverting to a more plastic state that allows them to participate in wound repair. This dedifferentiation–redifferentiation cycle, increasingly recognized through lineage-tracing studies, demonstrates that epithelial regeneration is not limited to classical stem cells but involves dynamic cellular reprogramming. RЕSULTS АND DISСUSSIОN ISSN: 2582-4686 SJIF 2021-3.261,SJIF 20222.889, 2024-6.875 ResearchBib IF: 9.948 / 2024 VOLUME-5, ISSUE-12 241 A key event during inflammation-induced regeneration is epithelial–mesenchymal crosstalk, which governs cell survival, migration, and tissue remodeling. Pro-inflammatory cytokines such as IL-6, TNF-α, and IL-1β initiate a controlled activation of NF-κB and STAT3 pathways, promoting epithelial cell proliferation while simultaneously modulating the inflammatory response. In parallel, fibroblasts and mesenchymal stem cells release extracellular matrix (ECM) components and remodeling enzymes (MMPs), creating a scaffold for epithelial migration [2]. This interaction ensures appropriate wound closure; however, excessive or prolonged cytokine activity may lead to maladaptive responses such as hyperplasia, impaired barrier function, or epithelial–mesenchymal transition (EMT), contributing to chronic inflammatory diseases. An essential regenerative mechanism is restitution, the rapid migration of epithelial cells across the injured surface before proliferation begins. This process is driven by cytoskeletal reorganization, integrin signaling, and interactions with ECM proteins such as laminin and fibronectin. Restitution is particularly critical in high-turnover epithelia such as the gastrointestinal tract, where damage must be repaired within hours to restore barrier integrity. Growth factors including TGF-β and trefoil peptides (TFFs) play a central role in promoting this early migration and stabilizing cell–cell junctions. As inflammation resolves, epithelial cells gradually re-establish polarity, restore tight junctions, and resume normal differentiation patterns [3]. Chronic inflammation introduces unique challenges for epithelial regeneration. Persistent cytokine production, oxidative stress, and repeated cycles of tissue destruction lead to stem-cell exhaustion, impaired differentiation, and structural distortion of epithelial architecture. In diseases such as ulcerative colitis, chronic gastritis, chronic rhinosinusitis, and chronic dermatitis, epithelial regeneration becomes dysregulated, resulting in metaplasia, atrophy, or fibrosis. Moreover, prolonged inflammatory signaling may induce mutagenic stress, setting the stage for inflammation-associated carcinogenesis. Aberrations in pathways such as Wnt/β-catenin, Notch, and Hedgehog, which normally support regenerative proliferation, can drive uncontrolled growth and neoplastic transformation when chronically activated. The clinical significance of understanding epithelial regeneration during inflammation extends across multiple medical disciplines. In gastroenterology, therapeutic strategies aim to enhance mucosal healing in inflammatory bowel diseases, acknowledging that complete epithelial restoration predicts long-term remission better than symptomatic control. In pulmonology, targeting epithelial repair mechanisms is crucial in chronic obstructive pulmonary disease (COPD) and asthma, where dysfunctional regeneration contributes to airway remodeling. Dermatology heavily relies on epithelial regenerative processes in wound care, burn treatment, and the management of chronic ulcers, where impaired epithelial closure can result in infection or scarring. Furthermore, regenerative medicine and tissue engineering increasingly explore the use of stem-cell therapies, growth factor delivery, and biomaterial scaffolds to accelerate epithelial healing in both acute and chronic inflammatory conditions. In summary, epithelial regeneration during inflammation is a sophisticated, multi-layered biological process that integrates stem-cell activation, regulated proliferation, migration, ECM remodeling, and immune signaling. Its success determines whether tissues regain full function or enter pathological cycles that lead to chronic disease or malignancy. Advances in cellular biology and histopathology continue to uncover the fine details of this regenerative orchestration, offering new therapeutic opportunities to harness or correct these mechanisms in clinical practice [4]. ISSN: 2582-4686 SJIF 2021-3.261,SJIF 20222.889, 2024-6.875 ResearchBib IF: 9.948 / 2024 VOLUME-5, ISSUE-12 242 СОNСLUSIОN Epithelial tissue regeneration during inflammation is a finely regulated process essential for maintaining organ integrity and functional recovery. Regeneration depends on the activation of epithelial stem cells, controlled proliferation and migration, dynamic interactions with mesenchymal cells, and precise modulation of inflammatory signaling. When these mechanisms function harmoniously, epithelial barriers are rapidly restored, preventing infection, fluid loss, and further tissue damage. However, chronic or dysregulated inflammation disrupts normal regenerative programs, leading to structural alterations such as metaplasia, hyperplasia, atrophy, and fibrosis, and may even initiate carcinogenic pathways. Understanding the molecular coordination between inflammation and epithelial repair has profound clinical importance, guiding modern therapeutic approaches aimed at enhancing mucosal healing, reducing chronic tissue damage, and preventing inflammation-associated malignancies. Continued research in this field promises new strategies in regenerative medicine and targeted anti-inflammatory therapy. RЕFЕRЕNСЕS 1. Shaykhiev R., Crystal R. G. Epithelial stem cells and chronic respiratory diseases. – Journal of Clinical Investigation, 2014. – Vol. 124(11). – P. 4319–4326. 2. Iizuka M., Konno S. Wound healing and signaling pathways in epithelial regeneration. – Journal of Dermatological Science, 2011. – Vol. 59(2). – P. 89–96. 3. Turner J. R. Intestinal mucosal barrier function in health and disease. – Nature Reviews Immunology, 2009. – Vol. 9. – P. 799–809. 4. Kubo A., Nagao K., Amagai M. Epidermal barrier formation and epithelial repair. – Annual Review of Cell and Developmental Biology, 2012. – Vol. 28. – P. 467–499.